Robert A. Kleczynski - 03 Feb 2025 Form 4 Insider Report for EXELON CORP (EXC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
04 Feb 2025, 17:14:43 UTC
Prior SEC filing
31 Jan 2024
Next SEC filing
26 Feb 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
David T Skinner, attorney-in-fact for Robert A Kleczynski

Key filing fact

Robert A. Kleczynski filed Form 4 for EXELON CORP (EXC) on 04 Feb 2025.

Key facts

  • This page summarizes Robert A. Kleczynski's Form 4 filing for EXELON CORP (EXC).
  • 12 reported transactions and 8 derivative rows are listed below.
  • Accepted by SEC: 04 Feb 2025, 17:14.

Change

  • Previous filing in this sequence was filed on 31 Jan 2024.
  • Current net transaction value: -$208,530.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EXC transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,233
Change %
+5.4%
Price
Shares after
24,272
Date
03 Feb 2025
Ownership
Direct
Footnotes
F1
EXC transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,422
Change %
+5.9%
Price
Shares after
25,694
Date
03 Feb 2025
Ownership
Direct
Footnotes
F1
EXC transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,624
Change %
+6.3%
Price
Shares after
27,318
Date
03 Feb 2025
Ownership
Direct
Footnotes
F1
EXC transaction

Common Stock

Options Exercise

Transaction value
Shares
+5,749
Change %
+21%
Price
Shares after
33,067
Date
03 Feb 2025
Ownership
Direct
Footnotes
F2
EXC transaction

Common Stock

Tax liability

Transaction value
$126,092
Shares
-3,108
Change %
-9.4%
Price
$40.57
Shares after
29,959
Date
03 Feb 2025
Ownership
Direct
EXC transaction

Common Stock

Disposed to Issuer

Transaction value
$82,438
Shares
-2,032
Change %
-6.8%
Price
$40.57
Shares after
27,927
Date
03 Feb 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EXC transaction Derivative

2022 Restricted Stock Units

Options Exercise

Transaction value
Shares
-1,233
Change %
-100%
Price
Shares after
0
Date
03 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,233
Exercise price
Footnotes
F1, F3
EXC transaction Derivative

2023 Restricted Stock Units

Options Exercise

Transaction value
Shares
-1,422
Change %
-50%
Price
Shares after
1,421
Date
03 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,422
Exercise price
Footnotes
F1, F4
EXC transaction Derivative

2024 Restricted Stock Units

Options Exercise

Transaction value
Shares
-1,624
Change %
-33%
Price
Shares after
3,246
Date
03 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,624
Exercise price
Footnotes
F1, F5
EXC transaction Derivative

2025 Restricted Stock Units

Award

Transaction value
$0
Shares
+6,101
Change %
Price
$0.000000
Shares after
6,101
Date
03 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,101
Exercise price
Footnotes
F1
EXC transaction Derivative

2022-2024 Performance Shares

Award

Transaction value
$0
Shares
+5,749
Change %
Price
$0.000000
Shares after
5,749
Date
03 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,749
Exercise price
Footnotes
F2
EXC transaction Derivative

2022-2024 Performance Shares

Options Exercise

Transaction value
Shares
-5,749
Change %
-100%
Price
Shares after
0
Date
03 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,749
Exercise price
Footnotes
F2
EXC holding Derivative

Retention RSUs

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
22,258
Date
03 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
22,258
Exercise price
Footnotes
F6, F7
EXC holding Derivative

Deferred phantom share equivalents

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,736
Date
03 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,736
Exercise price
Footnotes
F8, F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

Restricted stock unit (RSU) award granted under the Exelon Long-Term Incentive Plan (LTIP). Award vests in 1/3 increments at the January or February meeting of the Exelon Talent Management and Compensation Committee (TMCC) with each RSU representing the right to receive one share of Exelon common stock upon vesting. The award accrues additional RSUs each quarter through automatic dividend reinvestment, and the additional RSUs vest on the same schedule as the underlying award.

Footnote F2

Performance share award granted under the LTIP for the three-year performance period referenced in Column 1 based upon the TMCC's determination of performance achieved for the period. Each performance share represents the right to receive one share or the cash equivalent of one share pursuant to the LTIP's terms with respect to individual stock ownership levels. Performance share awards vest immediately on their grant date.

Footnote F3

Balance at the time of this vesting includes 49 additional shares acquired through automatic dividend reinvestment during 2024.

Footnote F4

Balance at the time of this vesting includes 113 additional shares acquired through automatic dividend reinvestment during 2024.

Footnote F5

Balance at the time of this vesting includes 194 additional shares acquired through automatic dividend reinvestment during 2024.

Footnote F6

Restricted stock unit (RSU) award granted under the Exelon LTIP on February 25, 2022. Each RSU represents the right to receive one share of Exelon common stock upon vesting. The award accrues additional RSUs each quarter through automatic dividend reinvestment and the additional RSUs vest on the same schedule as the underlying award. The award will cliff vest on February 25, 2025.

Footnote F7

Balance includes 887 additional shares acquired through automatic dividend reinvestment during 2024.

Footnote F8

Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. The stock fund is a unitized fund that consists of both Exelon common stock and short-term liquid investments. Units of the fund are acquired through quarter-end contributions and dividend reinvestment and will be settled for cash upon the termination of the reporting person. The balance of phantom share equivalents may fluctuate due to changes in the value of the fund units.

Footnote F9

Balance as of January 31, 2025. Balance includes 65 additional phantom share equivalents acquired during 2024 through automatic dividend reinvestment.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .